Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. (Q45887796)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation.
scientific article

    Statements

    Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit